The ROCkeTS study is a diagnostic study which aims to validate new tests/risk prediction models that estimate the probability of having ovarian cancer in pre and post-menopausal women with symptoms. The ROCkeTS-GEN substudy is also a diagnostic study but only recruiting post-menopausal women with the aim of evaluating patients' circulating tumour DNA (ctDNA) using genome sequencing to determine if ctDNA can be used as a diagnostic biomarker and thus improve the sensitivity of detecting ovarian cancer.
- 0121 415 9129
Birmingham Clinical Trials Unit
Public Health Building
University of Birmingham
Last Updated: 01/03/2023
|Year||Access Requests Received||Access Requests Approved|